• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

Unilever United States, Inc. - Close Out Letter 5/10/11


Department of Health and Human Services' logoDepartment of Health and Human Services

Public Health Service
Food and Drug Administration
 College Park, MD 20740

May 10, 2011

Nancy L. Schnell
U.S. Deputy General Counsel
Marketing & Regulatory
Unilever, Inc.
800 Sylvan Avenue
Englewood Cliffs, NJ 07632-3113 

Re: CFSAN-OC-10-24 

Dear Ms. Schnell:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter dated August 23, 2010. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.



Kathleen M. Lewis, J.D.
Team Leader
Labeling Compliance Team
Office of Compliance
Center for Food Safety
and Applied Nutrition